These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 25090005)

  • 21. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
    Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
    World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
    Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
    Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.
    Sun X; Li Y; Yu J; Pei H; Luo P; Zhang J
    Jpn J Clin Oncol; 2015 May; 45(5):474-82. PubMed ID: 25921099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer.
    Ling S; Ruiqin M; Guohong Z; Ying W
    Eur J Gynaecol Oncol; 2015; 36(4):463-8. PubMed ID: 26390704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis.
    Gao H; Li X; Zhan G; Zhu Y; Yu J; Wang J; Li L; Wu W; Liu N; Guo X
    Cell Cycle; 2019 Jun; 18(12):1393-1406. PubMed ID: 31122127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma.
    Wang Y; Yan S; Liu X; Zhang W; Li Y; Dong R; Zhang Q; Yang Q; Yuan C; Shen K; Kong B
    Oncol Rep; 2014 Apr; 31(4):1905-10. PubMed ID: 24573236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.
    Wang S; Zhao X; Wang J; Wen Y; Zhang L; Wang D; Chen H; Chen Q; Xiang W
    Med Oncol; 2013; 30(3):681. PubMed ID: 23918241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.
    Li J; Shao W; Zhao J
    Hum Cell; 2021 Mar; 34(2):570-578. PubMed ID: 33196969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
    Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
    Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
    Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Lee YS; Cho YL
    Anticancer Res; 2015 May; 35(5):2611-7. PubMed ID: 25964536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
    Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.